Intractable pruritus in patients with hepatitis C virus

Area of Science:

• Hepatology
• Nephrology
• Gastroenterology

Background:

• Intractable pruritus is a debilitating symptom in chronic liver disease, significantly impacting quality of life.
• Prolonged cholestasis often exacerbates pruritus, leading to sleep disturbances and psychological distress, sometimes necessitating liver transplantation.
• Current medical therapies for pruritus in chronic liver disease can be ineffective.

Purpose of the Study:

• To evaluate the efficacy of the molecular adsorbent recirculating system (MARS) in managing intractable pruritus in patients with chronic liver disease.
• To assess the impact of MARS treatment on liver function, renal function, and pruritus severity.

Main Methods:

• Nine patients with hepatitis C virus and intractable pruritus underwent MARS treatment.
• Liver function (total bilirubin, bile acids), renal function (creatinine), and hemodynamic variables were monitored before and after MARS therapy.
• Abdominal ultrasound or CT scans were performed to rule out organic causes of pruritus.

Main Results:

• All patients experienced a reduction in total bilirubin, creatinine, and bile acids.
• A significant improvement in pruritus severity, measured by the Visual Analog Scale, was observed in all treated patients.
• Despite observed improvements, the small sample size precluded statistically significant results.

Conclusions:

• MARS therapy shows promise in alleviating intractable pruritus associated with chronic liver disease.
• The system may improve liver and renal function markers in this patient population.
• Further research with larger cohorts is warranted to confirm the efficacy and significance of MARS treatment for pruritus in chronic liver disease.